24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BioProtect
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:10
U.S. strike signals Iran’s oil lifeline is no longer untouchable
20:41
Why did Zim’s CEO sell $40 million in shares before the $4.2 billion Hapag-Lloyd deal?
14:59
Wiz CEO Assaf Rappaport’s tech group to acquire Israeli broadcaster Reshet 13 from Len Blavatnik
13:13
“Iran is attempting an inflationary attack on the American consumer, raising fuel prices to create political pressure to end the war”
More stories
Buzz
Most popular
Daily
Weekly
1
Wiz billionaires forming private family office to manage proceeds from $32 billion Google exit
2
Fresh Fund founder Zaki Djemal dies suddenly
3
“Within 10 years, there will be at least 10 more Israeli companies like Wiz”
4
One-year-old AI startup Wonderful raises $150 million Series B at $2 billion valuation
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news
BioProtect
3 stories about BioProtect
Is it time to reconsider PSA tests for Prostate Cancer?
01.09.22
|
Itay Barnea
“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect
Which Israeli cancer treatment company raised $57 million and who is making money off double chins?
22.09.20
|
CTech
CTech Daily Roundup: Medtronic invests $4.5 million as part of BioProtect $25 million series D
Medtronic invests $4.5 million as part of BioProtect $25 million series D
22.09.20
|
Meir Orbach
Proceeds of the round will finance the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy